Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1981-06-12
1983-05-03
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
043820816
ABSTRACT:
Mammalian collagenase is inhibited by compounds of the formula ##STR1## or salts thereof, wherein R is hydrogen, alkanoyl of 2 to 10 carbon atoms or arylcarbonyl;
REFERENCES:
patent: 4235885 (1980-11-01), Sundeen et al.
"Structure-Inhibition Relationships Among Metal-binding Collagen Peptide Analogues", Hossain Saneii* and Arno F. Spatola* (SPON: John W. Brown), University of Louisville, Louisville, KY 40292, May 1, 1981, vol. 40, No. 6.
Dejneka Tamara
Sundeen Joseph E.
E. R. Squibb & Sons Inc.
Levinson Lawrence S.
Phillips Delbert R.
Rodney Burton
LandOfFree
Inhibitors of mammalian collagenase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of mammalian collagenase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of mammalian collagenase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1208951